POLX vs. CREO, IUG, NCYT, IHC, AVO, MHC, RUA, BELL, SUN, and DEMG
Should you be buying Polarean Imaging stock or one of its competitors? The main competitors of Polarean Imaging include Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), RUA Life Sciences (RUA), Belluscura (BELL), Surgical Innovations Group (SUN), and Deltex Medical Group (DEMG). These companies are all part of the "medical devices" industry.
Polarean Imaging vs.
Creo Medical Group (LON:CREO) and Polarean Imaging (LON:POLX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, community ranking, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.
Creo Medical Group received 83 more outperform votes than Polarean Imaging when rated by MarketBeat users. However, 67.65% of users gave Polarean Imaging an outperform vote while only 67.52% of users gave Creo Medical Group an outperform vote.
56.1% of Creo Medical Group shares are held by institutional investors. Comparatively, 12.1% of Polarean Imaging shares are held by institutional investors. 22.4% of Creo Medical Group shares are held by insiders. Comparatively, 39.3% of Polarean Imaging shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Creo Medical Group had 6 more articles in the media than Polarean Imaging. MarketBeat recorded 6 mentions for Creo Medical Group and 0 mentions for Polarean Imaging. Creo Medical Group's average media sentiment score of 0.11 beat Polarean Imaging's score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the media.
Creo Medical Group has a net margin of -73.93% compared to Polarean Imaging's net margin of -1,333.97%. Creo Medical Group's return on equity of -41.79% beat Polarean Imaging's return on equity.
Creo Medical Group has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Polarean Imaging has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500.
Creo Medical Group has higher revenue and earnings than Polarean Imaging. Creo Medical Group is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.
Summary
Creo Medical Group beats Polarean Imaging on 10 of the 15 factors compared between the two stocks.
Get Polarean Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for POLX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Polarean Imaging Competitors List
Related Companies and Tools
This page (LON:POLX) was last updated on 2/22/2025 by MarketBeat.com Staff
